» Articles » PMID: 37496613

Strategies for Targeted Gene Delivery Using Lipid Nanoparticles and Cell-derived Nanovesicles

Overview
Journal Nanoscale Adv
Specialty Biotechnology
Date 2023 Jul 27
PMID 37496613
Authors
Affiliations
Soon will be listed here.
Abstract

Gene therapy is a promising approach for the treatment of many diseases. However, the effective delivery of the cargo without degradation is one of the major hurdles. With the advent of lipid nanoparticles (LNPs) and cell-derived nanovesicles (CDNs), gene delivery holds a very promising future. The targeting of these nanosystems is a prerequisite for effective transfection with minimal side-effects. In this review, we highlight the emerging strategies utilized for the effective targeting of LNPs and CDNs, and we summarize the preparation methodologies for LNPs and CDNs. We have also highlighted the non-ligand targeting of LNPs toward certain organs based on their composition. It is highly expected that continuing the developments in the targeting approaches of LNPs and CDNs for the delivery system will further promote them in clinical translation.

Citing Articles

Nucleic Acid Conjugates: Unlocking Therapeutic Potential.

Kashyap D, Booth M ACS Bio Med Chem Au. 2025; 5(1):3-15.

PMID: 39990950 PMC: 11843337. DOI: 10.1021/acsbiomedchemau.4c00092.


Boosting Lipofection Efficiency Through Enhanced Membrane Fusion Mechanisms.

Pavlov R, Akimov S, Dashinimaev E, Bashkirov P Int J Mol Sci. 2025; 25(24.

PMID: 39769303 PMC: 11677079. DOI: 10.3390/ijms252413540.


Antigen-specific T cell immunotherapy by in vivo mRNA delivery.

Su F, Siebart J, Chan C, Wang M, Yao X, Trenkle A bioRxiv. 2024; .

PMID: 39554121 PMC: 11566043. DOI: 10.1101/2024.10.29.620946.


Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.

Haghighi E, Abolmaali S, Dehshahri A, Mousavi Shaegh S, Azarpira N, Tamaddon A J Nanobiotechnology. 2024; 22(1):710.

PMID: 39543630 PMC: 11566655. DOI: 10.1186/s12951-024-02972-w.


Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics.

Vasileva O, Zaborova O, Shmykov B, Ivanov R, Reshetnikov V Front Pharmacol. 2024; 15:1466337.

PMID: 39508050 PMC: 11537937. DOI: 10.3389/fphar.2024.1466337.


References
1.
Chen C, Wang J, Sun M, Li J, Wang H . Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery. Biomed Pharmacother. 2021; 145:112416. DOI: 10.1016/j.biopha.2021.112416. View

2.
Di H, Zeng E, Zhang P, Liu X, Zhang C, Yang J . General Approach to Engineering Extracellular Vesicles for Biomedical Analysis. Anal Chem. 2019; 91(20):12752-12759. DOI: 10.1021/acs.analchem.9b02268. View

3.
Skupin-Mrugalska P, Zalewski T, Elvang P, Nowaczyk G, Czajkowski M, Piotrowska-Kempisty H . Insight into theranostic nanovesicles prepared by thin lipid hydration and microfluidic method. Colloids Surf B Biointerfaces. 2021; 205:111871. DOI: 10.1016/j.colsurfb.2021.111871. View

4.
Lv P, Liu X, Chen X, Liu C, Zhang Y, Chu C . Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy. Nano Lett. 2019; 19(5):2993-3001. DOI: 10.1021/acs.nanolett.9b00145. View

5.
Andra V, Pammi S, Bhatraju L, Ruddaraju L . A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents. Bionanoscience. 2022; 12(1):274-291. PMC: 8790012. DOI: 10.1007/s12668-022-00941-x. View